GLP-1 Market
LLY $1136.11 ▼ -0.2% NVO $42.53 ▼ -2.1% PFE $27.55 ▼ -0.6% VKTX $29.95 ▼ -5.0% KLRA $13.45 ▼ -2.2% GPCR $38.95 ▲ +1.3% RHHBY $54.90 ▲ +0.2%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Ferric Citrate

Company
Dhaka Medical College
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 16, 2026

Find a Clinical Trial Near Me

See recruiting studies for Ferric Citrate and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04741646

    Ferric Citrate and Chronic Kidney Disease in Children

    Not yet reported University of California, Los Angeles 160 participants Est. completion 2028-11-30 20 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT07381426

    Ferric Citrate in Iron Deficiency Anemia During Pregnancy

    Not yet reported Dhaka Medical College 680 participants Est. completion 2027-03-31 1 site Stand-alone
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00648167

    A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)

    Not yet reported Keryx Biopharmaceuticals 55 participants Est. completion 2009-01 1 site Stand-alone
    Other conditions: Hyperphosphatemia, End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00967993

    Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

    Keryx Biopharmaceuticals 22 participants Est. completion 2010-05 3 sites
    Other conditions: Hyperphosphatemia, End-stage Renal Disease, Renal Failure Chronic Requiring Hemodialysis
    View official trial listing →
  • Completed NCT NCT01074125

    A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

    Not yet reported Keryx Biopharmaceuticals 154 participants Est. completion 2010-11 16 sites Stand-alone
    Other conditions: Hyperphosphatemia, End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01191255

    A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

    Not yet reported Keryx Biopharmaceuticals 441 participants Est. completion 2013-02 56 sites Stand-alone
    Other conditions: Hyperphosphatemia, Kidney Failure
    View official trial listing →
  • Completed NCT NCT01503736

    A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

    Not yet reported Panion & BF Biotech Inc. 183 participants 5 sites Stand-alone
    Other conditions: Hyperphosphatemia, End Stage Renal Disease, ESRD
    View official trial listing →
  • Completed NCT NCT01554982

    A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis

    Not yet reported Keryx Biopharmaceuticals 168 participants Est. completion 2014-08 34 sites
    Other conditions: End Stage Renal Disease, Kidney Failure, Renal Failure, Hyperphosphatemia, ESRD
    View official trial listing →
  • Completed NCT NCT01736397

    Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis

    Not yet reported Keryx Biopharmaceuticals 149 participants Est. completion 2013-12 20 sites Stand-alone
    Other conditions: Iron Deficiency, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT02128074

    A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia

    Not yet reported Keryx Biopharmaceuticals 32 participants Est. completion 2014-11 3 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02268994

    KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD

    Not yet reported Keryx Biopharmaceuticals 234 participants Est. completion 2016-01 36 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02492620

    Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D

    Not yet reported Denver Nephrologists, P.C. 200 participants Est. completion 2017-11 1 site
    Chronic kidney disease Other conditions: Hyperphosphatemia, Iron Deficiency Anemia, Renal Insufficiency
    View official trial listing →
  • Terminated NCT NCT02661295

    A Study of Ferric Citrate to Improve Inflammation and Lipid Levels

    Not yet reported Winthrop University Hospital 38 participants Est. completion 2018-03-15 1 site
    Other conditions: End Stage Renal Disease, Hyperphosphatemia, Chronic Inflammation
    View official trial listing →
  • Completed NCT NCT02888171

    Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency

    Not yet reported University of Alabama at Birmingham 60 participants Est. completion 2019-03-30 1 site Stand-alone
    Chronic kidney disease Other conditions: Iron Deficiency, Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT03055598

    Ferric Citrate in ESRD Pilot Project

    Not yet reported Sreedhar Mandayam 30 participants Est. completion 2020-02 2 sites Stand-alone
    Chronic kidney disease Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT03079869

    Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients

    Not yet reported Kaiser Permanente 55 participants Est. completion 2019-09-14 1 site
    Other conditions: Hyperphosphatemia
    View official trial listing →
  • Completed NCT NCT03236246

    KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

    Not yet reported Keryx Biopharmaceuticals 206 participants Est. completion 2019-09-27 28 sites Stand-alone
    Chronic kidney disease Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT03256838

    Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

    Not yet reported Panion & BF Biotech Inc. 202 participants Est. completion 2019-05-31 9 sites Stand-alone
    Other conditions: Kidney Failure, Chronic, End-stage Renal Disease, Phosphorus Metabolism Disorders, Hyperphosphatemia
    View official trial listing →
  • Completed NCT NCT03457701

    Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)

    Not yet reported GlaxoSmithKline 15 participants Est. completion 2022-07-05 3 sites Stand-alone
    Other conditions: Anaemia
    View official trial listing →
  • Completed NCT NCT03824587

    Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy

    Not yet reported, Not yet reported Ardelyx 236 participants Est. completion 2019-07-17 48 sites
    Other conditions: Hyperphosphatemia
    View official trial listing →
  • Completed NCT NCT03984760

    Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

    Not yet reported Panion & BF Biotech Inc. 240 participants Est. completion 2021-02-20 24 sites Stand-alone
    Other conditions: Hyperphosphatemia, End Stage Renal Disease, ESRD
    View official trial listing →
  • Completed NCT NCT04299633

    Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

    Not yet reported Akebia Therapeutics 54 participants Est. completion 2020-09-28 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04456803

    Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

    Not yet reported Sinomune Pharmaceutical Co., Ltd 239 participants Est. completion 2022-09-13 20 sites Stand-alone
    Other conditions: Hyperphosphatemia, End Stage Renal Disease, ESRD
    View official trial listing →
  • Suspended NCT NCT04523727

    Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

    Not yet reported Keryx Biopharmaceuticals 45 participants Est. completion 2027-10 14 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT04543812

    PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD

    Not yet reported Panion & BF Biotech Inc. 141 participants Est. completion 2022-12-16 12 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Withdrawn NCT NCT04649411

    Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease

    Not yet reported Keryx Biopharmaceuticals Est. completion 2027-03 Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT04922645

    Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

    Not yet reported USRC Kidney Research 214 participants Est. completion 2022-09-15 13 sites Stand-alone
    Other conditions: Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT05085275

    Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

    Not yet reported USRC Kidney Research 289 participants Est. completion 2024-01-24 23 sites Stand-alone
    Other conditions: Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic, Renal Anemia, Disease Progression, Cardiovascular, Iron
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Ferric Citrate, Ferric citrate 210 mg

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.